RegeneRx Biopharmaceuticals, Inc. (RGRX)
Develops eye drops and wound-healing drugs from a natural healing protein
$0.00+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-88.0%
The outlook
RGRX is trading near its 52-week low at $0.0006, with analyst coverage thin and a bearish lean overall. The stock shows mixed positioning relative to its moving averages, reflecting no clear directional momentum. Current data suggests significant weakness, though this micro-cap name carries high risk and limited analyst visibility.
What’s behind the score
Price trendMixed vs its moving averages
52-week range0% of the way from its 52-week low to high
Market cap
$898
52-wk high
$0.16
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—